CHARLES RIVER LABORATORIES (CRL) Stock Institutional Trading Activity


CHARLES RIVER LABORATORIES (CRL) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Ariel Appreciation Fund, Sequoia Financial Advisors, Meritage Group, and Polen Capital Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCSell-68,30910,200$2,034,696
Q4 2025Ariel Appreciation FundSell-62,3271,427,771$284,811,759
Q3 2025Sequoia Financial AdvisorsSell-2233,209$502,059
Q3 2025Ariel Appreciation FundBuy74,7501,490,098$233,140,733
Q2 2025Sequoia Financial AdvisorsBuy1,6773,432$520,738
Q2 2025Ariel Appreciation FundBuy314,5721,415,348$214,750,752
Q1 2025Sequoia Financial AdvisorsSell-2071,755$264,163
Q1 2025Ariel Appreciation FundBuy33,4491,100,776$165,688,804
Q4 2024Sequoia Financial AdvisorsSell-7,5691,962$362,186
Q4 2024Polen Capital ManagementSell-1,2564,248$784,181
Q4 2024Ariel Appreciation FundBuy169,6401,067,327$197,028,565
Q4 2024Meritage GroupSell-111,0471,074,120$198,282,552
Q3 2024Jensen Investment ManagementSell-3,73012,180$2,399,095
Q3 2024Polen Capital ManagementSell-2115,504$1,084,123
Q3 2024Sequoia Financial AdvisorsSell-4,6859,531$1,877,322
Q3 2024Ariel Appreciation FundSell-8,450897,687$176,817,408
Q3 2024Meritage GroupBuy2,5101,185,167$233,442,344
Q2 2024Jensen Investment ManagementSell-7,77015,910$3,286,688
Q2 2024Ariel Appreciation FundSell-26,670906,137$187,189,782
Q2 2024Polen Capital ManagementSell-3455,715$1,180,605
Q2 2024Sequoia Financial AdvisorsBuy66514,216$2,936,742
Q2 2024Meritage GroupBuy3891,182,657$244,313,283
Q1 2024Jensen Investment ManagementSell-1,85023,680$6,416,096
Q1 2024Ariel Appreciation FundSell-117,891932,807$252,744,056
Q1 2024Meritage GroupBuy26,8921,182,268$320,336
Q1 2024Polen Capital ManagementSell-2686,060$1,641,957
Q1 2024Sequoia Financial AdvisorsSell-55713,551$3,671,674
Q4 2023Ariel Appreciation FundSell-15,9021,050,698$248,385,007
Q4 2023Meritage GroupBuy271,7431,155,376$273,131
Q4 2023Polen Capital ManagementBuy1,3236,328$1,495,939

Frequently asked questions about CRL activity

  • Which institutional owners are buying CRL?

    Institutional owners buying CRL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CRL activity?

    "Buy" means an investor increased their reported position in CRL compared to the prior reporting period. This reflects growing exposure to CHARLES RIVER LABORATORIES (CRL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CRL increasing?

    Institutional interest in CRL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.